- Redefining In-Breast Tumor Recurrence: Unveiling Metastatic Dynamics and Shifting the Focus to Overall Survival in Breast Cancer Surgery Assessment
-
Mokbel K, Alamoodi M
- KMID: 2550426
- J Breast Cancer.
- 2023 Dec;26(6):593-596.
- doi: 10.4048/jbc.2023.26.e50
-
- CITED
-
- Close
- SHARE
-
- Close
- Residual Risk of Ipsilateral Tumor Recurrence in Patients Who Achieved Clear Lumpectomy Margins After Repeated Resection
-
Cheun JH, Kim HK, Lee HB, Han W, Moon HG
- KMID: 2550423
- J Breast Cancer.
- 2023 Dec;26(6):558-571.
- doi: 10.4048/jbc.2023.26.e46
Purpose: Patients with breast cancer with positive lumpectomy margins have a two-fold increased risk of ipsilateral breast tumor recurrence (IBTR). This can be the result of either technically incomplete resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer
-
Baek SY, Kim HK, Park S, Yu JH, Lee MH, Youn HJ, Kim HA, Han JH, Choi JE, Lee JR, Lee KH, Chung S, Chae HD, Kim S, Yoo S, Hahm SK, Kim HJ
- KMID: 2550425
- J Breast Cancer.
- 2023 Dec;26(6):582-592.
- doi: 10.4048/jbc.2023.26.e44
Purpose: Fertility preservation (FP) is an important issue for young survivors of breast cancer. Although international guidelines recommend pre-treatment fertility counseling for women with breast cancer, there is no standardized... -
- CITED
-
- Close
- SHARE
-
- Close
- Characterization of Expression and Function of the Formins FHOD1, INF2, and DAAM1 in HER2-Positive Breast Cancer
-
Peippo M, Gardberg M, Kronqvist P, Carpén O, Heuser VD
- KMID: 2550421
- J Breast Cancer.
- 2023 Dec;26(6):525-543.
- doi: 10.4048/jbc.2023.26.e47
Purpose: Human epidermal growth factor receptor 2 (HER2)-targeted therapies, such as trastuzumab, benefit patients with HER2-positive metastatic breast cancer; however, owing to traditional pathway activation or alternative signaling, resistance persists.... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer
-
Kim N, Kim H, Hwang JH, Lee JE, Park W, Cho WK, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Im YH, Ahn JS, Park YH, Kim JY, Kim TG
- KMID: 2550422
- J Breast Cancer.
- 2023 Dec;26(6):544-557.
- doi: 10.4048/jbc.2023.26.e43
Purpose: Data on subsequent arm lymphedema (SAL) after salvage treatment for locoregional recurrence (LRR) of breast cancer are limited. We conducted a study to evaluate the risk of SAL in... -
- CITED
-
- Close
- SHARE
-
- Close
- Intrathecal Catheter for Chemotherapy in Leptomeningeal Carcinomatosis From HER2-Negative Metastatic Breast Cancer
-
Dupoiron D, Autier L, Lebrec N, Seegers V, Folliard C, Patsouris A, Campone M, Augereau P
- KMID: 2550424
- J Breast Cancer.
- 2023 Dec;26(6):572-581.
- doi: 10.4048/jbc.2023.26.e40
Purpose: Most oncological treatments for leptomeningeal metastasis (LM) do not cross the blood-brain barrier (BBB). One therapeutic option is intrathecal (IT) chemotherapy. Both the brain-implanted Omaya reservoir and lumbar puncture... -
- CITED
-
- Close
- SHARE
-
- Close
